Eko Health vs Noom

Side-by-side comparison of AI visibility scores, market position, and capabilities

Noom leads in AI visibility (86 vs 73)
Eko Health logo

Eko Health

LeaderHealthcare

AI-Powered Digital Stethoscope & Cardiac Diagnostics

Eko Health has sold 700,000+ digital stethoscopes with FDA-cleared AI for murmur, AFib, and low ejection fraction detection; AMA granted a Category III CPT code for its Sensora AI platform in 2025.

AI VisibilityBeta
Overall Score
B73
Category Rank
#99 of 596
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
76
Perplexity
70
Gemini
78

About

Eko Health is a medical technology company that has reimagined the stethoscope by integrating digital amplification, ECG capture, and artificial intelligence into a clinical-grade device for heart and lung auscultation. Its flagship product, the CORE 500™ digital stethoscope, features 40x sound amplification, active noise cancellation, a 3-lead ECG, a full-color display, and FDA-cleared AI algorithms for detecting heart murmurs, atrial fibrillation (AFib), and low left ventricular ejection fraction (LVEF) — a key indicator of developing heart failure. Eko has sold more than 700,000 stethoscopes worldwide, establishing broad clinical adoption ahead of any direct competitor.

Full profile
Noom logo

Noom

GrowthHealthcare

Weight Health Platform

Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.

AI VisibilityBeta
Overall Score
A86
Category Rank
#12 of 596
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
81
Gemini
92

About

Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.

Full profile

AI Visibility Head-to-Head

73
Overall Score
86
#99
Category Rank
#12
74
AI Consensus
67
stable
Trend
stable
76
ChatGPT
80
70
Perplexity
81
78
Gemini
92
68
Claude
90
75
Grok
83

Key Details

Category
AI-Powered Digital Stethoscope & Cardiac Diagnostics
Weight Health Platform
Tier
Leader
Growth
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Noom
Weight Health Platform

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.